home / stock / gmab / gmab message board
Subject | By | Source | When |
---|---|---|---|
Emylers: GMXAY Financials 07/16/2014 18:58:03 Genmab A/S Period Ending Total Revenue Cost of Revenue | Emylers | investorshangout | 07/16/2014 11:57:58 PM |
chartguy89: GMXAY 22.23 Stock Charts $GMXAY 1 Month Chart | chartguy89 | investorshangout | 03/07/2014 5:48:58 PM |
chartguy89: GMXAY Stock Charts Last: -0.44 Wednesday, February 26, 2014 at 12:53:33 PM $GMXAY | chartguy89 | investorshangout | 02/26/2014 5:53:45 PM |
News, Short Squeeze, Breakout and More Instantly...
Genmab A/S Company Name:
GMAB Stock Symbol:
NYSE Market:
Sixteen abstracts accepted for presentation and publication demonstrate depth and breadth of comprehensive epcoritamab development program Three oral presentations highlight novel data evaluating epcoritamab in patients with relapsed/refractory (R/R) follicular lymphoma (FL), in combinati...
2024-05-11 10:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
May 2, 2024 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2024 Highlights The U.S. Food and Drug Administration (U.S. FDA) granted Priority Review for the supplemental Biologics License Application (sBLA) for EPKINLY ® (epcorita...